On Apr. 30, 2020, Vaxart announced it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Antibody responses in all vaccinated groups were statistically significant compared to the untreated controls.